Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo

Sanna, M Germana, Wang, Sheng-Kai, Gonzalez-Cabrera, Pedro J, Don, Anthony, Marsolais, David, Matheu, Melanie P, Wei, Sindy H, Parker, Ian +5 more·2006·Nature Chemical Biology
DOI 10.1038/nchembio804

Cited by (417)

Items 101–200 of 417

  1. Translational aspects of sphingosine 1-phosphate biology
    Susan Pyne, Nigel J. Pyne · 2011 · Trends in Molecular Medicine
  2. Balance of S1P1and S1P2signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature
    Jen-Fu Lee, Sharon Gordon, Rosendo Estrada, Lichun Wang, Deanna L. Siow, Binks W. Wattenberg, David G. Lominadze, Menq-Jer Lee · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
  3. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
    Simona Federica Spampinato, Birgit Obermeier, Anne C Cotleur, Anna C. Love, Yukio Takeshita, Yasuteru Sano, Takashi Kanda, Richard M. Ransohoff · 2015 · PLoS ONE
  4. Sphingosine kinase 1 protects against renal ischemia–reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation
    Sang Won Park, Minjae Kim, Mihwa Kim, Vivette Denise D’Agati, H. Thomas Lee · 2011 · Kidney International
  5. T cell-intrinsic S1PR1 regulates endogenous effector T-cell egress dynamics from lymph nodes during infection
    Alexandre Pierre Benechet, Manisha Menon, Daqi Xu, Tasleem Samji, Leigh A. Maher, Thomas T. Murooka, Thorsten R. Mempel, Brian S. Sheridan, Francois Michel Lemoine, Kamal Mohan Khanna · 2016 · Proceedings of the National Academy of Sciences
  6. Signaling Required for Blood Vessel Maintenance: Molecular Basis and Pathological Manifestations
    Masahiro Murakami · 2011 · International Journal of Vascular Medicine
  7. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
    Yugesh Kharel, Thomas P. Mathews, Amanda M. Gellett, Jose Luis Tomsig, Perry Kennedy, Morgan L. Moyer, Timothy L. Macdonald, Kevin R. Lynch · 2011 · Biochemical Journal
  8. Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1–mediated vascular endothelial barrier enhancement
    Geerte L. Van Sluis, Tatjana M.H. Niers, Charles T. Esmon, Wikky Tigchelaar, Dick J. Richel, Harry Roger Buller, Cornelis J.F. Van Noorden, C. Arnold Spek · 2009 · Blood
  9. Lysophospholipid receptors in vertebrate development, physiology, and pathology
    Athanasia Skoura, Timothy Hla · 2008 · Journal of Lipid Research
  10. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
    Daniela Salvemini, Timothy M. Doyle, Michaela Kress, G. D. Nicol · 2013 · Trends in Pharmacological Sciences
  11. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
    N. Rostami, A. Nikkhoo, Amir Ajoolabady, G. Azizi, M. Hojjat-Farsangi, G. Ghalamfarsa, B. Yousefi, M. Yousefi, Farhad Jadidi-Niaragh · 2019 · Molecular Diagnosis & Therapy
  12. Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease
    Sung-Yoon Jo, Amandeep Bajwa, Alaa S. Awad, Kevin R. Lynch, Mark Douglas Okusa · 2008 · Kidney International
  13. Lyase to live by: Sphingosine phosphate lyase as a therapeutic target
    Ashok Kumar, Julie Deane Saba · 2009 · Expert Opinion on Therapeutic Targets
  14. Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system
    Mirjam Schuchardt, Markus Tölle, Jasmin Prüfer, Markus van der Giet · 2011 · British Journal of Pharmacology
  15. A sphingosine 1-phosphate receptor 2 selective allosteric agonist
    Hideo Satsu, Marie‐Therese Schaeffer, Miguel A. Guerrero, Adrian Saldana, Christina Eberhart, Peter Hodder, Charmagne S. Cayanan, Stephan C. Schürer, Barun Bhhatarai, Ed Roberts et al. · 2013 · Bioorganic & Medicinal Chemistry
  16. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation
    Sang Won Park, Mihwa Kim, Sean W. C. Chen, Kevin M Brown, Vivette Denise D’Agati, H. Thomas Lee · 2010 · Laboratory Investigation
  17. Successful Strategies to Determine High-Resolution Structures of GPCRs
    Jin Xiang, Eugene Chun, Chang Liu, Liang Jing, Zina Al-Sahouri, Lan Zhu, Wei Liu · 2016 · Trends in Pharmacological Sciences
  18. Modulating tone: the overture of S1P receptor immunotherapeutics
    Hugh Rosen, Pedro J. Gonzalez‐Cabrera, David Marsolais, Stuart M. Cahalan, Anthony Simon Don, Marta Sanna · 2008 · Immunological Reviews
  19. The role of sphingosine-1-phosphate in endothelial barrier function
    Brent A. Wilkerson, Kelley M. Argraves · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  20. Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues—Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist
    Ran Zhu, Ashley Hall Snyder, Yugesh Kharel, Lisa M. Schaffter, Qin Sun, Perry Kennedy, Kevin R. Lynch, Timothy L. Macdonald · 2007 · Journal of Medicinal Chemistry
  21. Expansion of Cortical and Medullary Sinuses Restrains Lymph Node Hypertrophy during Prolonged Inflammation
    Kar Wai Tan, Kim Pin Yeo, Fiona H. S. Wong, Hwee Ying Lim, Kai Ling Khoo, Jean‐Pierre Abastado, Véronique Angeli · 2012 · The Journal of Immunology
  22. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice
    Gema Tarrasón, Mariona Aulí, Sanam Mustafa, Vladislav A. Dolgachev, Teresa Domènech, Neus Prats, María Domínguez, Rosa López, Núria Aguilar, Marta Calbet et al. · 2011 · International Immunopharmacology
  23. Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to Influenza
    David Marsolais, Bumsuk Hahm, Kurt H. Edelmann, Kevin B. Walsh, Miguel A. Guerrero, Yasuko Hatta, Yoshihiro Kawaoka, Edward Roberts, Michael B. A. Oldstone, Hugh Rosen · 2008 · Molecular Pharmacology
  24. Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
    Luke M. Healy, Jack Perry Antel · 2015 · Current Drug Targets
  25. Alteration of sphingolipid metabolism as a putative mechanism underlying <scp>LPS</scp>‐induced <scp>BBB</scp> disruption
    Vutukuri, Rajkumar, Brunkhorst, Robert, Kestner, Roxane‐Isabelle, Hansen, Lena, Bouzas, Nerea Ferreiros, Pfeilschifter, Josef, Devraj, Kavi, Pfeilschifter, Waltraud · 2018 · Journal of Neurochemistry
  26. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction
    Ilyse Darwish, Wayne Conrad Liles · 2013 · Virulence
  27. Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1receptor modulator: Favorable impact of dose up-titration
    Patrick Brossard, Michael W. Scherz, Atef Halabi, Haidar Maatouk, Andreas Krause, Jasper Dingemanse · 2014 · The Journal of Clinical Pharmacology
  28. Synthetic Analogs of FTY720 [2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] Differentially Regulate Pulmonary Vascular Permeability in Vivo and in Vitro
    S. M. Camp, Robert Bittman, Eddie T. Chiang, Liliana Moreno‐Vinasco, Tamara Mirzapoiazova, Saad Sammani, X. Lu, C.Y. Sun, Mark C. Harbeck, M. Roe et al. · 2009 · Journal of Pharmacology and Experimental Therapeutics
  29. Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca 2+ Sensitivity and Na + /H + Exchange and Mediates Protection by Ischemic Preconditioning
    Petra Keul, Marcel M. G. J. van Borren, Alexander Ghanem, Frank Ulrich Müller, Antonius Baartscheer, Arie O. Verkerk, Frank T. Stümpel, Jan Sebastian Schulte, Nazha Hamdani, Wolfgang Albrecht Linke et al. · 2016 · Journal of the American Heart Association
  30. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn
    Suzanne Doolen, Tommaso Iannitti, Renée R. Donahue, Benjamin C. Shaw, Carolyn M. Grachen, Bradley Kenneth Taylor · 2017 · Pain
  31. Fingolimod treatment in multiple sclerosis leads to increased macular volume
    Rachel C. Nolan, Jeffrey Marc Gelfand, Ari Green · 2012 · Neurology
  32. Discontinued Postnatal Thymocyte Development in Sphingosine 1-Phosphate-Lyase-Deficient Mice
    Claudia Weber, Andreas Krueger, Anika Münk, Constantin Bode, Paul P. Van Veldhoven, Markus H. Gräler · 2009 · The Journal of Immunology
  33. Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression
    Mandi M. Murph, Gordon Brent Mills · 2007 · Expert Reviews in Molecular Medicine
  34. Amelioration of Collagen-Induced Arthritis by a Novel S1P1 Antagonist with Immunomodulatory Activities
    Yasuyuki Fujii, Takehiro Hirayama, Hidenori Ohtake, Naoya Ono, Tomoyuki Inoue, Takanobu Sakurai, Tetsuo Takayama, Kayo Matsumoto, Narutoshi Tsukahara, Shinya Hidano et al. · 2011 · The Journal of Immunology
  35. Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism
    Amanda Finley, Zhoumou Chen, Emanuela Esposito, Salvatore Cuzzocrea, Roger Allen Sabbadini, Daniela Salvemini · 2013 · PLoS ONE
  36. The Role of Sphingosine-1-Phosphate in Breast Cancer Tumor-Induced Lymphangiogenesis
    Tomoyoshi Aoyagi, Masayuki Nagahashi, Akimitsu Yamada, Kazuaki Takabe · 2012 · Lymphatic Research and Biology
  37. Sphingosine kinase 1 in viral infections
    Jillian M. Carr, Suresh Mahalingam, Claudine S. Bonder, Stuart Maxwell Pitson · 2012 · Reviews in Medical Virology
  38. S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification
    John Ross Teijaro, Sean Studer, Nora B. Leaf, William Bill Kiosses, Nhan Nguyen, Kosuke Matsuki, Hideo Negishi, Tadatsugu Taniguchi, Michael B. A. Oldstone, Hugh Rosen · 2016 · Proceedings of the National Academy of Sciences
  39. Modulators of the Sphingosine 1-phosphate receptor 1
    Mariangela Urbano, Miguel A. Guerrero, Hugh Rosen, Edward Roberts · 2013 · Bioorganic & Medicinal Chemistry Letters
  40. Therapeutic Potential of Targeting SK1 in Human Cancers
    Heba A Alshaker, Lysann Sauer, Danielle C. Monteil, Silvia Ottaviani, Shyam Srivats, Torsten Böhler, Dmitri Pchejetski · 2013 · Advances in cancer research
  41. Sphingolipids in Lung Endothelial Biology and Regulation of Vascular Integrity
    Taimur A. Abbasi, Joe G. N. Garcia · 2013 · Handbook of experimental pharmacology
  42. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice
    Hong Cui, Yasuo Okamoto, Kazuaki Yoshioka, Wa Du, Noriko Takuwa, Wei Zhang, Masahide Asano, Toshishige Shibamoto, Yoh Takuwa · 2013 · Journal of Allergy and Clinical Immunology
  43. Guanine Nucleotide-Binding Proteins of the G12 Family Shape Immune Functions by Controlling CD4+ T Cell Adhesiveness and Motility
    Susanne Herroeder, Peter Reichardt, Antonia Sassmann, Barbara Zimmermann, Dagmar Jaeneke, Jana Hoeckner, Markus Werner Hollmann, Klaus‐Dieter Fischer, Stephan Vogt, Robert Grosse et al. · 2009 · Immunity
  44. Ligand-Binding Pocket Shape Differences between Sphingosine 1-Phosphate (S1P) Receptors S1P1 and S1P3 Determine Efficiency of Chemical Probe Identification by Ultrahigh-Throughput Screening
    Stephan C. Schürer, Steven J Brown, Pedro J. Gonzalez‐Cabrera, Marie‐Therese Schaeffer, Jacqueline V. Chapman, Euijung Jo, Peter S. Chase, Timothy Spicer, Peter Hodder, Hugh Rosen · 2008 · ACS Chemical Biology
  45. Sphingolipids in Lung Growth and Repair
    Jeroen Tibboel, Irwin K. M. Reiss, Johan C. de Jongste, Martin Post · 2014 · CHEST Journal
  46. Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction
    Marta Sanna, Kevin P. Vincent, Emanuela Repetto, Nhan Nguyen, Steven J Brown, Lusine Abgaryan, Sean Riley, Nora B. Leaf, Stuart M. Cahalan, William Bill Kiosses et al. · 2015 · Molecular Pharmacology
  47. Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer Therapeutics and Drug Resistance
    Shanmugam Panneer Selvam, Besim Öğretmen · 2013 · Handbook of experimental pharmacology
  48. Building a Pharmacological Lexicon: Small Molecule Discovery in Academia
    John Stephen Lazo, Linda S. Brady, Raymond J Dingledine · 2007 · Molecular Pharmacology
  49. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3
    Chao Li, Jun-nan Li, Joanne S. Kays, Miguel A. Guerrero, G. D. Nicol · 2015 · Journal of Neuroinflammation
  50. A role for LFA‐1 in delaying T‐lymphocyte egress from lymph nodes
    Peter Reichardt, Irene M. Patzak, Kristian Jones, Eloho Etemire, Matthias Gunzer, Nancy Hogg · 2013 · The EMBO Journal
  51. Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
    Martin Sebastian Winkler, Konstantin B. Märtz, Axel Nierhaus, Günter Daum, Edzard Schwedhelm, Stefan Kluge, Markus H. Gräler · 2019 · Journal of Intensive Care
  52. LPS and TNF-α induce expression of sphingosine-1-phosphate receptor-2 in human microvascular endothelial cells
    Jing Du, Chong Zeng, Qiang Li, Bo Chen, Hongxia Liu, Xuliang Huang, Qiaobing Huang · 2012 · Pathology - Research and Practice
  53. Sphingosine-1-Phosphate Signaling in Endothelial Disorders
    Teresa Sánchez · 2016 · Current Atherosclerosis Reports
  54. The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk
    Thomas Bärnthaler, Jovana Marić, Wolfgang Platzer, Viktória Kónya, Anna Theiler, Carina Hasenoehrl, Benjamin Gottschalk, Sandra Trautmann, Yannick Schreiber, Wolfgang F. Graier et al. · 2017 · Scientific Reports
  55. Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1
    Mien Van Hoang, Janice A. Nagy, Donald R. Senger · 2010 · Blood
  56. Sphingolipid Regulation of Tissue Fibrosis
    Barry S. Shea, Andrew Martin Tager · 2012 · The Open Rheumatology Journal
  57. Bioluminescence imaging of G protein-coupled receptor activation in living mice
    Mari Kono, Elizabeth G. Conlon, Samantha Y. Lux, Keisuke Yanagida, Timothy Hla, Richard L. Proia · 2017 · Nature Communications
  58. Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate
    Sven-Christian Sensken, Claudia Stäubert, Petra Keul, Bodo Levkau, Torsten Schöneberg, Markus H. Gräler · 2008 · Cellular Signalling
  59. Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
    Anthony Simon Don, Xin Ying Lim, Timothy A. Couttas · 2014 · Biomolecules
  60. FTY720 (fingolimod) for relapsing multiple sclerosis
    A. Horga, X. Montalban · 2008 · Expert Review of Neurotherapeutics
  61. Targeting Sphingosine 1-phosphate (S1P) Levels and S1P Receptor Functions for Therapeutic Immune Interventions
    Markus H. Gräler · 2010 · Cellular Physiology and Biochemistry
  62. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C
    Hitoshi Ikeda, Ryunosuke Ohkawa, Naoko Watanabe, Kazuhiro Nakamura, Yukio Kume, Hayato Nakagawa, Haruhiko Yoshida, Shigeo Okubo, Hiromitsu Yokota, Tomoaki Tomiya et al. · 2010 · Clinica Chimica Acta
  63. Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules
    Gengqian Zhang, Sulei Xu, Yan Qian, Pingnian He · 2010 · American Journal of Physiology-Heart and Circulatory Physiology
  64. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors
    Dong‐Soon Im · 2010 · Acta Pharmacologica Sinica
  65. Sphingosine-1-Phosphate Receptors: Zooming in on Ligand-Induced Intracellular Trafficking and Its Functional Implications
    Dennis Verzijl, Stephan L.M. Peters, Astrid E. Alewijnse · 2010 · Molecules and Cells
  66. Activation of sphingosine-1-phosphate receptor 1 in the spinal cord produces mechano-hypersensitivity through the activation of inflammasome and IL-1β pathway
    T. Doyle, Zhoumou Chen, M. Durante, D. Salvemini · 2019 · Journal of Pain
  67. Sphingosine kinase 1 as an anticancer therapeutic target
    Ying Gao, Fei Gao, Kan Chen, Meili Tian, Dongli Zhao · 2015 · Drug Design Development and Therapy
  68. Lipid phosphate phosphatase (LPP3) and vascular development
    Hongmei Ren, Manikandan Panchatcharam, P. Mueller, Diana Escalante‐Alcalde, Andrew J. Morris, Susan S. Smyth · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  69. Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
    Ambra Vestri, Federica Pierucci, Alessia Frati, Lucia Monaco, Elisabetta Meacci · 2017 · Frontiers in Pharmacology
  70. Lipids - two sides of the same coin in lung fibrosis
    Argen Mamazhakypov, RALPH THEO SCHERMULY, Liliana Schaefer, Małgorzata Wygrecka · 2019 · Cellular Signalling
  71. Impact of sphingosine 1-phosphate modulation on immune outcomes
    Daniel D. Pinschewer, Volker Brinkmann, Doron Merkler · 2011 · Neurology
  72. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme
    Sandra Bien-Möller, Sandra Lange, Tobias Holm, Andreas Böhm, Heiko Paland, Johannes Küpper, Susann Herzog, Kerstin Weitmann, Christoph Havemann, Silke Vogelgesang et al. · 2016 · Oncotarget
  73. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair
    Ziad Sartawi, Ernestina Schipani, Katie B. Ryan, Christian Waeber · 2017 · Pharmacological Research
  74. Effects of Lysophospholipids on Tumor Microenvironment
    Johannes Rolin, Azzam A. Maghazachi · 2011 · Cancer Microenvironment
  75. Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats
    Timothy M. Doyle, Amanda Finley, Zhoumou Chen, Daniela Salvemini · 2011 · Pain
  76. Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways
    Pankaj Goyal, Daniela Brünnert, Jonas Ehrhardt, Melissa Bredow, Svea Piccenini, Marek Zygmunt · 2013 · Molecular Human Reproduction
  77. Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis
    Claudia Volpi, Ciriana Orabona, Antonio Macchiarulo, Roberta Bianchi, Paolo Puccetti, Ursula Grohmann · 2019 · Expert Opinion on Drug Discovery
  78. Characterization of a Sphingosine 1-Phosphate Receptor Antagonist Prodrug
    Perry Kennedy, Ran Zhu, Tao Huang, Jose Luis Tomsig, Thomas P. Mathews, Marion David, Olivier Peyruchaud, Timothy L. Macdonald, Kevin R. Lynch · 2011 · Journal of Pharmacology and Experimental Therapeutics
  79. Mesenchymal stem cells in radiation-induced lung injury: From mechanisms to therapeutic potential
    Guowen Hou, Jinjie Li, Wenyun Liu, Jinlong Wei, Ying Xin, Xin Mei Jiang · 2022 · Frontiers in Cell and Developmental Biology
  80. Sphingosine-1-phosphate receptors as emerging targets for treatment of pain
    Sandra P. Welch, Laura J. Sim‐Selley, Dana E. Selley · 2012 · Biochemical Pharmacology
  81. Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations
    Dow P. Hurst, Marianne G. Schmeisser, Patricia H. Reggio · 2013 · Chemistry and Physics of Lipids
  82. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells
    Anja Völzke, Alexander Hemdorff Koch, Dagmar Meyer zu Heringdorf, Andrea Huwiler, Josef M. Pfeilschifter · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  83. S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission
    Linlu Tian, Yongxia Wu, Hee-Jin Choi, Xiaohui Sui, Xinlei Li, Mohammed Hanief Sofi, Mohamed Faisal Kassir, Xiao Chen, Shikhar Mehrotra, Besim Öğretmen et al. · 2022 · Cellular and Molecular Immunology
  84. Lipid metabolites as regulators of airway smooth muscle function
    Deborah L. Clarke, Shyamala Dakshinamurti, Anna‐Karin Larsson‐Callerfelt, Jane Ward, Akira Yamasaki · 2008 · Pulmonary Pharmacology & Therapeutics
  85. How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
    Gehui Sun, Bin Wang, Xiaoyu Wu, Jiangfeng Cheng, Junming Ye, Chunli Wang, Hongquan Zhu, Xiaofeng Liu · 2024 · Frontiers in Immunology
  86. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: Analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog
    Kiyoaki Yonesu, Yumi Kawase, Tatsuya Inoue, Nana Takagi, Jun Tsuchida, Yoh Takuwa, Seiichiro Kumakura, Futoshi Nara · 2008 · Biochemical Pharmacology
  87. Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts
    Elena Rapizzi, Chiara Donati, Francesca Cencetti, Paola Nincheri, Paola Bruni · 2008 · Molecular and Cellular Biochemistry
  88. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
    Bárbara González‐Fernández, Diana I. Sánchez, Javier González‐Gallego, María Jesús Tuñón · 2017 · Frontiers in Pharmacology
  89. Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke
    Yu-Jing Li, Samuel Xiang-Yu Shi, Qiang Liu, Fu‐Dong Shi, Rayna J. Gonzales · 2020 · Neuroscience Letters
  90. Vascular biology: the role of sphingosine 1‐phosphate in both the resting state and inflammation
    David J. Swan, John Andrew Kirby, Simi Ali · 2010 · Journal of Cellular and Molecular Medicine
  91. Targeting Sphingosine-1-Phosphate Receptors in Cancer
    Rebecca Jean Watters, Hong‐Gang Wang, Shen‐Shu Sung, Thomas P. Loughran, Xin Liu · 2011 · Anti-Cancer Agents in Medicinal Chemistry
  92. Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
    David Garandeau, Justine Noujarède, Justine Leclerc, Caroline Imbert, Virginie Garcia, Marie‐Lise Bats, Florian Rambow, Julia Gilhodes, Thomas Filleron, Nicolás Meyer et al. · 2018 · Molecular Cancer Therapeutics
  93. Role of sphingosine 1-phosphate signalling in tissue fibrosis
    Chiara Donati, Francesca Cencetti, Caterina Bernacchioni, Valentina Vannuzzi, Paola Bruni · 2020 · Cellular Signalling
  94. S1P2 receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology
    Grant M. Sumida, William Daniel Stamer · 2011 · American Journal of Physiology-Cell Physiology
  95. Cardiovascular Effects of Sphingosine-1-Phosphate (S1P)
    Bodo Levkau · 2013 · Handbook of experimental pharmacology
  96. A ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages
    Meir Goldsmith, Dorit Avni, Galit Levy‐Rimler, Roi Mashiach, Orna Ernst, Maya Levi, Bill Webb, Michaël M. Meijler, Nathanael S. Gray, Hugh Rosen et al. · 2008 · Immunology
  97. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
    Stuart M. Cahalan, Pedro J. Gonzalez‐Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J Brown, Edward Roberts, Hugh Rosen · 2012 · Molecular Pharmacology
  98. Sphingosine-1-Phosphate Enhancement of Cortical Actomyosin Organization in Cultured Human Schlemm's Canal Endothelial Cell Monolayers
    Grant M. Sumida, William Daniel Stamer · 2010 · Investigative Ophthalmology & Visual Science
  99. Sphingosine 1‐phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes
    Collin Tran, Benjamin Heng, Jonathan D. Teo, Sean J. Humphrey, Yanfei Qi, Timothy A. Couttas, Holly Stefen, Merryn Brettle, Thomas Fath, Gilles J. Guillemin et al. · 2019 · Journal of Neurochemistry
  100. Development of oral immunomodulatory agents in the management of multiple sclerosis
    Richard S. Nicholas, Richard S. Nicholas, Giannetti, Ali Alsanousi, Paolo Antonio Muraro · 2011 · Drug Design Development and Therapy